Efficacy and safety of secukinumab over 52 weeks in Chinese psoriasis patients with concomitant psoriatic arthritis. Issue 21 (5th November 2021) - Cai, Lin; Zhang, Jian-Zhong; Zheng, Min; Zhang, Shi-Fa; Patekar, Manmath